APA

Halim M. A., Al-Otaibi T., Johny K. V., Hamid M. H., Al-Waheeb S., Hasaneen H., Awadain W. H., Nawas K. M., El-Sayed A., Said T., Nair M. P. & Nampoory M. R. N. (20100111). Early sirolimus therapy in renal transplant recipients at high risk: is it justified?. : Transplantation proceedings.

Chicago

Halim M A, Al-Otaibi T, Johny K V, Hamid M H, Al-Waheeb S, Hasaneen H, Awadain W H, Nawas K M, El-Sayed A, Said T, Nair M P and Nampoory M R N. 20100111. Early sirolimus therapy in renal transplant recipients at high risk: is it justified?. : Transplantation proceedings.

Harvard

Halim M. A., Al-Otaibi T., Johny K. V., Hamid M. H., Al-Waheeb S., Hasaneen H., Awadain W. H., Nawas K. M., El-Sayed A., Said T., Nair M. P. and Nampoory M. R. N. (20100111). Early sirolimus therapy in renal transplant recipients at high risk: is it justified?. : Transplantation proceedings.

MLA

Halim M A, Al-Otaibi T, Johny K V, Hamid M H, Al-Waheeb S, Hasaneen H, Awadain W H, Nawas K M, El-Sayed A, Said T, Nair M P and Nampoory M R N. Early sirolimus therapy in renal transplant recipients at high risk: is it justified?. : Transplantation proceedings. 20100111.